Reprogramming patients' cells offers powerful new tool for studying, treating blood diseases

First produced only in the past decade, human induced pluripotent stem cells (iPSCs) are capable of developing into many or even all human cell types. Scientists have now reprogrammed skin cells from patients with rare blood disorders into iPSCs, highlighting the great promise of these cells in advancing understanding of those challenging diseases -- and eventually in treating them.

Read the whole article on Science Daily

More from Science Daily